2 ‘unstoppable’ FTSE 100 shares I’d buy for a new ISA

The FTSE 100 includes some of the world’s best businesses. Our writer explores two high-quality picks that could bring long-term rewards.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Finger clicking a button marked 'Buy' on a keyboard

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

ISA season has arrived. 6 April was the first day I could add fresh funds to my Stocks and Shares ISA.

But with new money sitting there, I’m looking at which shares to buy next. More specifically, I’m considering FTSE 100 shares.

FTSE 100’s best retailer

The first Footsie share on my hit list is UK fashion/lifestyle retailer Next (LSE:NXT). I used to own this share many years ago when it was trading at around £10. Since then, it has multiplied by a whopping nine times.

Should you invest £1,000 in AstraZeneca right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if AstraZeneca made the list?

See the 6 stocks

A £5,000 investment would now be worth £43,500. It’s a shame I didn’t hold onto it. But that’s in the past. Next has been and continues to be an impressive operator.

Its business strategy over the years has kept it ahead of the competition, in my opinion. For instance, it was one of the first among peers to make a push towards online sales.

Today, it continues to innovate. For instance, it now operates a Total Platform product which allows third-party brands to use Next’s infrastructure services such as IT, warehousing and marketing.

This could be a key driver of future growth, especially in a changing retail environment.

A high-quality business

Next shares offer many of the characteristics that make a quality stock. For instance, it offers a double-digit return on capital employed. It’s also a profitable business that churns out free cash flow.

This enables it to reduce debt and return excess cash to shareholders.

Bear in mind that retail consumers still face elevated cost of living pressures. Weather can also play a part in a customer’s shopping habits. And both factors can impact near-term earnings.

That said, these are short-term factors. For the long-term, I’m confident that Next will continue to be one of the leading retailers in the UK.

That’s why this time when I buy the shares, I hope I hold on to them.

The big pharma giant

Another quality FTSE 100 share I’d buy is pharmaceutical giant Astrazeneca (LSE:AZN). It’s the Footsie’s second largest company, one spot behind Shell.

Astrazeneca is a world-class player in this industry. Over the past decade it has focused on research and development. And it now offers a rich pipeline of innovative medicine across oncology, biopharmaceuticals and rare diseases.

If executed well, this should provide an excellent source of earnings growth for many years.

Oncology represents 35% of its portfolio and sales rose 23% last year. I’d note that chief executive Pascal Soriot expects “another year of strong growth in 2024, driven by continued adoption of medicines across geographies”.

Spending spree

Astrazeneca has purchased several billion-dollar companies recently. And although this could strengthen its pipeline, it doesn’t come cheap. Large acquisitions tend to come with some risk too. That said, this mega-cap has ample experience to lean on.

It trades on a forward price to earnings ratio of 16. This is broadly in line with peers, but I’d say it’s not expensive given its strong pipeline and potential.

Overall, both FTSE 100 top picks could prove to be unstoppable players in a long-term ISA. That’s why I intend to buy them both soon.

But there may be an even bigger investment opportunity that’s caught my eye:

Investing in AI: 3 Stocks with Huge Potential!

🤖 Are you fascinated by the potential of AI? 🤖

Imagine investing in cutting-edge technology just once, then watching as it evolves and grows, transforming industries and potentially even yielding substantial returns.

If the idea of being part of the AI revolution excites you, along with the prospect of significant potential gains on your initial investment…

Then you won't want to miss this special report inside Motley Fool Share Advisor – 'AI Front Runners: 3 Surprising Stocks Riding The AI Wave’!

And today, we're giving you exclusive access to ONE of these top AI stock picks, absolutely free!

Get your free AI stock pick

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harshil Patel has no position in any of the shares mentioned. The Motley Fool UK has recommended AstraZeneca Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

This 1 moment changed Warren Buffett’s investment approach forever!

Our writer has learnt a valuable lesson from billionaire Warren Buffett, who changed his preferred investing style after a lightbulb…

Read more »

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

Could this overlooked FTSE 100 stock be the next Rolls-Royce?

Rolls-Royce's market cap was similar to this FTSE 100 firm just two-and-a-half years ago. Now it’s flying high. Could Melrose…

Read more »

Young female couple boarding their plane at the airport to go on holiday.
Investing Articles

Here’s how much passive income a 21-year-old investing £60 a week could earn by 35!

A 21-year-old putting this passive income into action today could realistically target a four-figure passive income by their mid-thirties. Here's…

Read more »

Female student sitting at the steps and using laptop
Investing Articles

£10,000 invested in Greggs shares a year ago is now worth…

Our writer goes through some of the recent price history for Greggs shares and explains why he's again decided to…

Read more »

British bank notes and coins
Investing Articles

With £10 a week, here’s how to start buying shares

Christopher Ruane says it's possible to start buying shares for a tenner a week. Here are some of the moves…

Read more »

Tesla building with tesla logo and two teslas in front
Investing Articles

Tesla stock’s up 75% in a year! Time to buy?

Tesla stock has soared in the past year. Our writer considers whether he ought to invest in the business at…

Read more »

Rear view image depicting a senior man in his 70s sitting on a bench leading down to the iconic Seven Sisters cliffs on the coastline of East Sussex, UK. The man is wearing casual clothing - blue denim jeans, a red checked shirt, navy blue gilet. The man is having a rest from hiking and his hiking pole is leaning up against the bench.
Investing Articles

Want to generate a £1,600 second income each year from a £20k ISA? Here’s how to try!

Stuffing an ISA with high-quality dividend shares is one way to build up passive income streams. Our writer explores how…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

This FTSE 100 company is down 33% this year. Here’s why I’m thinking of buying

The worst 2025 performer in the FTSE 100 has been hit by some fresh crises. Is it time for investors…

Read more »